A detailed history of Los Angeles Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 3,603,645 shares of BMY stock, worth $208 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
3,603,645
Previous 1,637,073 120.13%
Holding current value
$208 Million
Previous $68 Million 174.3%
% of portfolio
0.76%
Previous 0.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $78 Million - $102 Million
1,966,572 Added 120.13%
3,603,645 $186 Million
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $7.01 Million - $9.23 Million
-174,212 Reduced 9.62%
1,637,073 $68 Million
Q1 2024

Apr 05, 2024

SELL
$47.98 - $54.4 $4.89 Million - $5.55 Million
-101,964 Reduced 5.33%
1,811,285 $98.2 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $18.2 Million - $21.8 Million
376,367 Added 24.49%
1,913,249 $98.2 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $850,635 - $951,142
14,694 Added 0.97%
1,536,882 $89.2 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $44.3 Million - $49.2 Million
-696,054 Reduced 31.38%
1,522,188 $97.3 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $11.1 Million - $12.5 Million
-168,242 Reduced 7.05%
2,218,242 $154 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $10.6 Million - $12.5 Million
154,420 Added 6.92%
2,386,484 $172 Million
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $78,882 - $46.6 Million
606,788 Added 37.33%
2,232,064 $159 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $46.5 Million - $51.2 Million
640,465 Added 65.03%
1,625,276 $125 Million
Q1 2022

May 06, 2022

BUY
$61.48 - $73.72 $3.76 Million - $4.51 Million
61,139 Added 6.62%
984,811 $71.9 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $14.8 Million - $17.2 Million
275,507 Added 42.51%
923,672 $57.6 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $6.79 Million - $7.95 Million
-114,753 Reduced 15.04%
648,165 $38.4 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $5.32 Million - $5.79 Million
-85,863 Reduced 10.12%
762,918 $51 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $428,375 - $481,796
-7,219 Reduced 0.84%
848,781 $53.6 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $858,305 - $972,616
14,865 Added 1.77%
856,000 $53.1 Million
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $31.4 Million - $34.8 Million
-546,860 Reduced 39.4%
841,135 $50.7 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $909,573 - $1.06 Million
16,592 Added 1.21%
1,387,995 $81.6 Million
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $24 Million - $34.9 Million
517,959 Added 60.69%
1,371,403 $76.4 Million
Q4 2019

Feb 07, 2020

SELL
$49.21 - $64.19 $2.25 Million - $2.94 Million
-45,774 Reduced 5.09%
853,444 $54.8 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $1.26 Million - $1.49 Million
-29,421 Reduced 3.17%
899,218 $45.6 Million
Q2 2019

Jul 29, 2019

SELL
$44.62 - $49.34 $13.9 Million - $15.4 Million
-311,881 Reduced 25.14%
928,639 $42.1 Million
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $91.1 Million - $109 Million
-2,019,750 Reduced 61.95%
1,240,520 $59.2 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $59.7 Million - $77.4 Million
1,224,101 Added 60.12%
3,260,270 $169 Million
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $7.48 Million - $8.44 Million
135,605 Added 7.13%
2,036,169 $126 Million
Q2 2018

Jul 31, 2018

BUY
$50.53 - $62.98 $58.3 Million - $72.6 Million
1,153,130 Added 154.28%
1,900,564 $105 Million
Q1 2018

Apr 27, 2018

SELL
$59.92 - $68.98 $23.9 Million - $27.5 Million
-398,367 Reduced 34.77%
747,434 $47.3 Million
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $5.64 Million - $6.15 Million
-94,101 Reduced 7.59%
1,145,801 $70.2 Million
Q3 2017

Nov 06, 2017

SELL
$55.23 - $63.74 $10.8 Million - $12.4 Million
-194,908 Reduced 13.58%
1,239,902 $79 Million
Q2 2017

Aug 09, 2017

BUY
N/A
1,434,810
1,434,810 $79.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.